Stocks
Boston Scientific (BSX) EBITDA margin US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 15.2% | 21.2% | 21.6% | 25.4% | 24.2% | 23.5% | ||
| Changes by years, y/y, % | -5pp | +6pp | +0pp | +4pp | -1pp | -0.3% | |||
Boston Scientific. EBITDA margin, %
Boston Scientific. EBITDA margin, changes, pp
Boston Scientific (BSX) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | 27.3% | 23.7% | 25.5% | 19.7% | 25.1% | 23.5% | |
| Changes by years, y/y, % | +3pp | -1pp | +4pp | -2pp | -3pp | |||
| Changes by quarters, q/q, % | 0pp | -4pp | +2pp | -6pp | +5pp | |||
